Diane Hamann

Diane Hamann is a Principal Scientist at Rgenta Therapeutics Inc., with prior experience as a Principal Scientist at Syros Pharmaceuticals and a Research Scientist at the Broad Institute, focusing on drug discovery for complex therapeutic targets in cardiovascular disease and oncology. Diane has a strong track record in synthesizing compounds with improved affinity, leading collaborations, and supervising research associates. Academic credentials include a Ph.D. in Organic Chemistry from Boston University and a Master of Engineering in Chemistry from CPE Lyon. Diane's professional journey includes roles in several research laboratories, where significant contributions were made to synthetic chemistry and compound libraries.